We're excited to announce that LARVOL will be featured on New Frontiers this January 2025! ?? ?? In this special episode, we’ll explore how our Oncology Data Intelligence empowers pharmaceutical and biotech companies to make strategic, data-driven decisions that fuel innovation. From clinical trial insights to expert opinions, we can’t wait to showcase the impact of our work. ?? We’d love for you to tune in and join us! ?? Access the full press release: https://bit.ly/4d9qkAf Stay tuned for more details! #LARVOL #NewFrontiersTV #Oncology #OncologyData #CancerResearch #CancerData #ComingJanuary2025 #DataInnovation #PressRelease #PlanetTVStudios
LARVOL
IT 服务与咨询
San Francisco,California 11,871 位关注者
Empowering pharma, biotech, and life sciences with customized SaaS and expert intelligence since 2004.
关于我们
Customized intelligence reports and SaaS solutions - We provide healthcare and life sciences experts accurate, rapid, expertly-curated information to enable strategic decision-making. Our products include KOL monitoring, real-time high-impact news, intuitive cancer biomarker database and comprehensive conference planners. To keep you at the forefront of clinical and industry developments, LARVOL curates pharmaceutical and biotech competitive intelligence using a proven combination of broad therapeutic-area expertise and technological innovation. Our team of MDs and PhDs collates data from over 25,000 sources and distills the most relevant findings into concise reports that provide real-time insights and time-saving analysis. Our global team is comprised of professionals with expertise in all major therapeutic areas, with a special focus on oncology, inflammation, cardiovascular, and CNS. We are a valued partner to numerous Fortune 500 companies as well as small and mid-size pharma and biotech enterprises.
- 网站
-
https://www.larvol.com
LARVOL的外部链接
- 所属行业
- IT 服务与咨询
- 规模
- 51-200 人
- 总部
- San Francisco,California
- 类型
- 私人持股
- 创立
- 2004
- 领域
- Financial analyst monitoring、Scientific Conferences、life sciences、medical conferences和healthcare
产品
OMNI
Business Intelligence (BI) Software
Stay up-to-date with all aspects of your KOL activity. OMNI makes it easy with complete coverage of both on and offline news delivered in real-time to your inbox and our user-friendly online platform.
地点
-
主要
548 Mission St
Suite 44120
US,California,San Francisco,94105
LARVOL员工
-
Bruno Larvol
-
Vincent Guerlavais
Inventor & Drug Hunter, Senior Director Medicinal Chemistry & Drug Discovery
-
Sreedhar Reddy
Vice President - Product Management and Strategy at LARVOL | Building SaaS products for Pharma | Cancer clinical data | KOL tracking | Conferences |…
-
Vinod T.K.
Developer at The Larvol Group
动态
-
The latest episode of the LARVOL Onco Data Podcast is live! Join Mark Gramling and Darko Medin, as they explore Pseudo IPD in Cancer Research and the role of Network Meta-Analysis in oncology. Tune in now: https://bit.ly/3ZlpDQU #LARVOL #Oncology #CancerResearch #CancerData #OncoDataPodcast #MedicalPodcast #NetworkMetaAnalysis
-
In this episode, Mark Gramling is joined by Darko Medin for a dive into the complexities of network meta-analysis in oncology and its integration with pseudo-IPD (Individual Patient Data). The conversation explores how LARVOL’s CLIN platform is advancing data curation to enable comprehensive and predictive analyses in cancer research. Key topics include: ? The use of pseudo-IPD for combining treatment data ? The role of network meta-analysis in comparing multiple treatments simultaneously ? How combining direct and indirect evidence provides valuable insights in oncology Don’t miss out on this discussion on the power of big data and AI for more effective cancer treatment strategies.
LARVOL Onco Data Podcast: Pseudo-IPD and Network Meta-Analysis in Oncology
www.dhirubhai.net
-
?? Episode 8 of the 'LARVOL CLIN - Building In Public' Podcast is now live! Join Bruno Larvol and Kalpana Devi, Director at LARVOL, as they discuss the importance of the Landscape feature in LARVOL CLIN. This function compares main treatments with clinical trial data, offering valuable insights that serve as a guideline in oncology. It provides a comprehensive data table and the emerging data landscape for cancer patients. Tune in now: https://bit.ly/3V2Mwpr With LARVOL CLIN, stay informed and ahead in the fast-evolving world of oncology. Access key insights, stay updated on new developments, and leverage data intelligence to elevate your practice. Discover more: https://bit.ly/4da5h1k #LARVOL #Oncology #CancerResearch #MedicalOncology #CancerTreatment #OncologyUpdates #MedicalPodcast #LARVOLCLIN
-
Ahead of the American Society of Hematology 2024, we’ve highlighted the top diseases from the field of oncology. Save the date! We will be at ASH 2024 in San Diego, from December 7-10, showcasing innovative cancer data solutions. With LARVOL CLIN, you’ll remain at the cutting edge of the evolving oncology landscape. Access critical insights that drive your practice and stay ahead of industry trends. Don’t miss out—connect with us and stay informed ?? https://bit.ly/4da5h1k Connect with our leading oncology partners from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala| Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates
-
Are you ready for the American Society of Hematology 2024? We spotlight the leading MOAs. Connect us at ASH 2024 in San Diego, December 7-10, to explore the latest and AI-powered cancer data solutions. With LARVOL CLIN, you’ll be at the forefront of the rapidly evolving oncology landscape. Access essential insights that drive your practice and keep you updated on the latest industry trends. Stay ahead—connect with us and stay informed ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala| Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates
-
Ahead of the American Society of Hematology 2024, we're highlighting the top products from the dynamic field of oncology. Mark your calendars! LARVOL will be at ASH 2024 in San Diego from December 7-10, showcasing transformative cancer data solutions. To stay ahead of the curve in the ever-evolving oncology field and gain access to the critical insights that drive your practice, just connect with us at LARVOL CLIN ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala | Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates
-
In the lead-up to the American Society of Hematology 2024, we've spotlighted the top clinical trials trending among oncologists on X (formerly Twitter). Your oncology data partner, LARVOL is heading to ASH 2024! Meet us in San Diego for the latest cancer insights, December 7-10. Access the vital insights that drive your practice and stay updated on the latest from the dynamic oncology field with LARVOL CLIN ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Andrew Rezvani | Samer Al Hadidi | Raúl Córdoba Mascu?ano | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala | Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates
-
Leading up to the American Society of Hematology 2024, we're spotlighting the top companies driving innovation in oncology. Join LARVOL at ASH 2024 in San Diego to explore the latest in oncology data from December 7-10. Stay at the forefront of the rapidly advancing oncology landscape with LARVOL CLIN. Access the vital insights that matter most to your practice and stay informed about the latest industry breakthroughs ?? https://bit.ly/4da5h1k Reach out to our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala | Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates
-
As the American Society of Hematology (ASH) 2024 approaches, we’ve showcased the top reactions from leading oncologists on X (formerly Twitter). Our team will be in San Diego, California, from December 7-10, 2024, and we’re excited to meet and connect with everyone there. With LARVOL CLIN, access crucial insights that influence your practice and stay updated on the latest oncology developments?? https://bit.ly/4da5h1k Connect with our leading oncology leaders from the field of Heme-Onc: Amol Akhade | Vivek Subbiah, MD | Santhosh Ambika | Samer Al Hadidi | Toni Choueiri | Aakash Desai, MD, MPH | Mike Thompson, MD, PhD, FASCO | Bijoy Telivala | Ajay Major, MD, MBA | Stephanie Graff, MD, FACP, FASCO #LARVOL #Oncology #ASH24 #HemeOnc #Hematology #CancerResearch #LARVOLCLIN #OncologyUpdates